Guohong Ge

A Pilot Study of Serum MicroRNAs Panel as Potential Biomarkers for Diagnosis of Nonalcoholic Fatty Liver Disease

Youwen Tan, Guohong Ge, Tengli Pan et al. · PLoS ONE · 2014 · 170 citations · Full text

A Serum MicroRNA Panel as Potential Biomarkers for Hepatocellular Carcinoma Related with Hepatitis B Virus

Youwen Tan, Guohong Ge, Tengli Pan et al. · PLoS ONE · 2014 · 156 citations · Full text

Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter study

Jitao Wang, Zhiyun Hou, Jianxin Liu et al. · Journal of Hepatology · 2021 · 100 citations · Full text

Vaccination, Vaccine Safety, Hepatology +8

miR‑498 inhibits the growth and metastasis of liver cancer by targeting ZEB2

Xu Zhang, Xueying Xu, Guohong Ge et al. · Oncology Reports · 2018 · 79 citations · Full text

Tumor Biology, Oncology, Hepatology +13

Safety and Immunogenicity of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases (CHESS-NMCID 2101): A Multicenter Study

Jingwen Ai, Jitao Wang, Dengxiang Liu et al. · Clinical Gastroenterology and Hepatology · 2021 · 72 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +8